Pharmacists News

• Antimicrobial Resistance Linked to 1.2 Million Global Deaths Researchers take the largest look to date on the impact of bacterial antimicrobial resistance, including most affected agents and regions of the world.
  Medscape Medical News, January 20, 2022
• COVID at 2 Years: Preparing for a Different 'Normal' Experts hope for a better summer and envision an endemic status ahead where health systems will include COVID-19 as part of the yearly respiratory burden.
  Medscape Medical News, January 20, 2022
• How the Pandemic Led to Disarray ― and Discovery In the scramble to tackle the virus in real time, entrenched scientific and medical processes were challenged, sometimes leading to mixed results.
  Medscape Medical News, January 20, 2022
• The Virus Within: How Misinformation Made the Pandemic Worse Based in lack of trust that is often fanned by politicians, the media, and others, misinformation has not only caused arguments but arguably has also cost many lives.
  Medscape Medical News, January 20, 2022
• The Pandemic Has Changed Us, Permanently Over the past 2 years, Americans have made many changes to how they live, work, play, worship ― and manage their health. Many experts think some of these changes are here to stay.
  Medscape Medical News, January 20, 2022
• COVID-19 Survivors and Experts Share Pandemic 'Silver Linings' 'Benefit finding' is a skill among some of the more resilient people whose lives have been upended by COVID-19, and experts explain how it can help others.
  Medscape Medical News, January 20, 2022
• 'New Standard of Care' for HER2-Mutant NSCLC? Patients with non–small cell lung cancer harboring HER2 mutations experienced durable activity and promising survival outcomes with trastuzumab deruxtecan, a new study shows.
  Medscape Medical News, January 19, 2022
• 'Artificial Pancreas' Life-Changing in Kids With Type 1 Diabetes A semi-automated insulin delivery system using proprietary software improved time in target blood glucose range in young children aged 5 years, on average, with type 1 diabetes.
  Medscape Medical News, January 19, 2022
• Zinc May Worsen Rheumatoid Arthritis, Lab Study Suggests Zinc supplementation may exacerbate rheumatoid arthritis, new laboratory data suggest.
  Reuters Health Information, January 18, 2022
• Trial Will Test Synthetic Cannabinoid for Weight Loss in Obesity Although marijuana leads to the munchies, it is paradoxically tied to lower BMI. Following promising mouse studies, researchers will test the synthetic cannabinoid nabilone for weight loss in humans.
  Medscape Medical News, January 19, 2022
• Appendectomy or Antibiotics? Large Trial Helps Decision Making A study reinforces a link between appendicoliths and appendectomies after antibiotics, but its author said there's a surprising lack of connection for other factors that tilt patients toward surgery.
  Medscape Medical News, January 19, 2022
• Pediatric CAP: Short 5-Day Antibiotic Course Beats 10-Day Treatment of uncomplicated pediatric community-acquired pneumonia with a short, 5-day course of antibiotics results in a superior clinical response compared to the standard 10-day course.
  Medscape Medical News, January 19, 2022
• CVD Preventive Med Use Down During COVID-19 Pandemic Use of medications to manage cardiovascular disease risk factors significantly decreased during the COVID-19 pandemic in the UK and has not returned to prepandemic levels, a new study shows.
  First Look, January 18, 2022
• First FDA-Approved Hypersomnia Drug Data Published Lower-sodium oxybate improves idiopathic hypersomnia symptoms and might be a useful first-line therapy or monotherapy or used in combination with alerting agents, newly published data show.
  Medscape Medical News, January 18, 2022
• Gilead Says Counterfeiting Network Sold $250 Mln Worth of Its HIV Drugs Gilead Sciences said on Tuesday that tampered and counterfeit versions of its HIV treatments worth $250 million were sold to pharmacies over 2 years by a network of drug distributors and suppliers.
  Reuters Health Information, January 18, 2022
• Psychiatry Resident's Posts Reveal His Mental Health Battle After educating others about mental health through his popular social media platforms, 'Dr Jake' put his medical career on the line to expose his personal fight against mental illness.
  Medscape Medical News, January 18, 2022
• Could Probiotics Reduce 'Chemo Brain' in Breast Cancer Patients? Patients with breast cancer reported fewer symptoms of cognitive impairment associated with chemotherapy when they took a probiotics supplements, reports the first study of its kind.
  Medscape Medical News, January 18, 2022
• Long-Term Adjunctive Edaravone for ALS: Latest Findings Adding IV edaravone to riluzole for a year provides no additional benefit in terms of amyotrophic lateral sclerosis progression, time to ventilation, or survival versus riluzole alone, new research shows.
  Medscape Medical News, January 17, 2022
• Aduhelm Ancillary Costs to Push Medicare Spending Even Higher A new cost analysis taking into account spending on ancillary health services suggests that prior cost analyses underestimated the anticipated costs of aducanumab.
  Medscape Medical News, January 17, 2022
• FDA Approves Two Oral JAK Inhibitors for Atopic Dermatitis Upadacitinib and abrocitinib are the first oral JAK inhibitors approved for treating atopic dermatitis.
  Medscape Medical News, January 14, 2022